| 000 | 01734 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516150607.0 | ||
| 264 | 0 | _c20140305 | |
| 008 | 201403s 0 0 eng d | ||
| 022 | _a1205-7541 | ||
| 024 | 7 |
_a10.1139/cjpp-2012-0190 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDerakhshanian, Hoda | |
| 245 | 0 | 0 |
_aQuercetin prevents experimental glucocorticoid-induced osteoporosis: a comparative study with alendronate. _h[electronic resource] |
| 260 |
_bCanadian journal of physiology and pharmacology _cMay 2013 |
||
| 300 |
_a380-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAlendronate _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 | _aBody Mass Index |
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xpharmacology |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFemur _xdrug effects |
| 650 | 0 | 4 | _aGlucocorticoids |
| 650 | 0 | 4 |
_aMethylprednisolone Hemisuccinate _xpharmacology |
| 650 | 0 | 4 |
_aOsteogenesis _xdrug effects |
| 650 | 0 | 4 |
_aOsteoporosis _xblood |
| 650 | 0 | 4 | _aPilot Projects |
| 650 | 0 | 4 |
_aQuercetin _xpharmacology |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 700 | 1 | _aDjalali, Mahmoud | |
| 700 | 1 | _aDjazayery, Abolghassem | |
| 700 | 1 | _aNourijelyani, Keramat | |
| 700 | 1 | _aGhadbeigi, Sajad | |
| 700 | 1 | _aPishva, Hamideh | |
| 700 | 1 | _aSaedisomeolia, Ahmad | |
| 700 | 1 | _aBahremand, Arash | |
| 700 | 1 | _aDehpour, Ahmad Reza | |
| 773 | 0 |
_tCanadian journal of physiology and pharmacology _gvol. 91 _gno. 5 _gp. 380-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1139/cjpp-2012-0190 _zAvailable from publisher's website |
| 999 |
_c22734536 _d22734536 |
||